Cookies

To help make this website function we have placed cookies on your computer. You can see what cookies we have set at any time.
We'll assume that you're OK to continue using this site.

Don't show me this message again

Feedback:


The Essential Business Development Resource

Welcome to OTCToolbox. We produce online publications that enable business developers and innovators in the OTC/consumer healthcare industry worldwide make well-informed decisions. Find out more.

 

Latest news

Premium

RB takes new chief executive from PepsiCo

13 June 2019

RB has appointed PepsiCo's Laxman Narasimhan as its new chief executive officer. He will join the company on 16 July 2019 as chief executive officer designate, and will replace Rakesh Kapoor on 1 September 2019. More

Premium

EFSA issues new advice on phosphate levels

13 June 2019

The European Food Safety Authority (EFSA) is recommending there should be maximum permitted levels of phosphates used as additives in food supplements. It maintains that people who take food supplements regularly may be at risk. More

People in brief | Urgo, Juliet Seifert, PGEU, LEO

12 June 2019

Urgo Group has announced a new senior management team, Juliet Seifert has been honoured, the Pharmaceutical Group of the European Union (PGEU) has a new president, and LEO Pharma has a new chief executive officer. More

Premium

Stada snaps up six OTC brands from GSK

10 June 2019

Stada Arzneimittel is acquiring a portfolio of OTC brands, including Oilatum and Savlon Antiseptic Cream, from GlaxoSmithKline (GSK) Consumer Healthcare for an undisclosed sum. More

Premium

Dermapharm takes majority stake in Fitvia

10 June 2019

Dermapharm is acquiring a majority stake in German healthy nutrition company Fitvia for an undisclosed sum. The news came as Germany's Dermapharm reported sales up by 19.0% to EUR164 million (USD186 million) in the first quarter of 2019. More

Premium

Regulators must move quickly on CBD regulation

7 June 2019

The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is like the "wild west". More